Folate receptor mediated intracellular gene delivery using the charge changing solid lipid nanoparticles

References

• Antony, A.C. (1996). Folate receptors. Annu Rev Nutr, 16, 501–21.
   PubMed Web of Science ®Google Scholar
• Benns, J.M., Maheshwari, A., Furgeson, D.Y., Mahato, R.I., Kim, S.W. (2001). Folate-PEG-Folate-graft-polyethylenimine-based gene delivery. J Drug Target, 9, 123–39.
   PubMedGoogle Scholar
• Chan, P., Kurisawa, M., Chung, J.E., Yang, Y.Y. (2007). Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery. Biomaterials, 28, 540–9.
   PubMed Web of Science ®Google Scholar
• Cheung, S.T., Tsui, T.Y., Wang, W.L., Yang, Z.F., Wong, S.Y., Ip, Y.C., Luk, J., Fan, S.T. (2002). Liver as an ideal target for gene therapy: expression of CTLA4Ig by retroviral gene transfer. J Gastroenterol Hepatol, 17, 1008–14.
   PubMed Web of Science ®Google Scholar
• Cichon, G., Schmidt, H.H., Benhidjeb, T., Löser, P., Ziemer, S., Haas, R., Grewe, N., Schnieders, F., Heeren, J., Manns, M.P., Schlag, P.M., Strauss, M. (1999). Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits. J Gene Med, 1, 360–71.
   Google Scholar
• Corsi, K., Chellat, F., Yahia, L., Fernandes, J.C. (2003). Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials, 24, 1255–64.
   Google Scholar
• Dubé,; D., Francis, M., Leroux, J.C., Winnik, F.M. (2002). Preparation and tumor cell uptake of poly(N-isopropylacrylamide) folate conjugates. Bioconjug Chem, 13, 685–92.
   PubMed Web of Science ®Google Scholar
• Dubes, A., Parrot-Lopez, H., Abdelwahed, W., Degobert, G., Fessi, H., Shahgaldian, P., Coleman, A.W. (2003). Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins. Eur J Pharm Biopharm, 55, 279–82.
   PubMed Web of Science ®Google Scholar
• Escriou V, Ciolina C, Lacroix F, Byk G, Scherman D, Wils P. (1998). Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes. Biochim Biophys Acta,1368, 276–88.
   PubMed Web of Science ®Google Scholar
• Hejazi, R., Amiji, M. (2003). Chitosan-based gastrointestinal delivery systems. J Contr Rel, 89, 151–65.
   PubMed Web of Science ®Google Scholar
• Jeong, J.H., Kim, S.W., Park, T.G. (2003). A new antisense oligonucleotide delivery system based on self-assembled ODN-PEG hybrid conjugate micelles. J Contr Rel, 93, 183–91.
   PubMed Web of Science ®Google Scholar
• Jooss, K., Chirmule, N. (2003). Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy. Gene Ther, 10, 955–63.
   PubMedGoogle Scholar
• Ke, C.Y., Mathias, C.J., Green, M.A. (2003). The folate receptor as a molecular target for tumor-selective radionuclide delivery. Nucl Med Biol, 30, 811–7.
   PubMed Web of Science ®Google Scholar
• Komatsu, H., Kitajima, A., Okada, S. (1995). Pharmaceutical characterization of commercially available intravenous fat emulsions: estimation of average particle size, size distribution and surface potential using photon correlation spectroscopy. Chem Pharm Bull, 43, 1412–5.
   Google Scholar
• Leamon, C.P. (2002). Fusogenic lipids and vesicles for delivery of pharmaceutical agents. US Patent 6,379,698.
   Google Scholar
• Lincoln, D.T., Ali, Emadi EM, Tonissen, K.F., Clarke, F.M. (2003). The thioredoxin-thioredoxin reductase system: over expression in human cancer. Anticancer Res, 23, 2425–33.
   PubMed Web of Science ®Google Scholar
• Liu, W.G., Yao, K.D. (2002). Chitosan and its derivatives–a promising non-viral vector for gene transfection. J Contr Rel, 83, 1–11.
   PubMed Web of Science ®Google Scholar
• Lu, Y., Low, P.S. (2003). Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects. J Contr Rel, 91, 17–29.
   PubMed Web of Science ®Google Scholar
• MacLaughlin, F.C., Mumper, R.J., Wang, J., Tagliaferri, J.M., Gill, I., Hinchcliffe, M., Rolland, A.P. (1998). Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J Contr Rel, 56, 259–72.
   PubMed Web of Science ®Google Scholar
• Mansouri, S., Cuie, Y., Winnik, F., Shi, Q., Lavigne, P., Benderdour, M., Beaumont, E., Fernandes, J.C. (2006). Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials, 27, 2060–5.
   PubMed Web of Science ®Google Scholar
• Mao, S., Shuai, X., Unger, F., Simon, M., Bi, D., Kissel, T. (2004). The depolymerization of chitosan: effects on physicochemical and biological properties. Int J Pharm, 281, 45–54.
   PubMed Web of Science ®Google Scholar
• Mehnert, W., Mäder, K. (2001). Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev, 47, 165–96.
   PubMed Web of Science ®Google Scholar
• Müller, R.H., Jacobs, C., Kayser, O. (2001). Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future. Adv Drug Deliv Rev, 47, 3–19.
   PubMed Web of Science ®Google Scholar
• Müller, R.H., Mäder, K., Gohla, S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery: a review of the state of the art. Eur J Pharm Biopharm, 50, 161–77.
   PubMed Web of Science ®Google Scholar
• Nathwani, A.C., Davidoff, A.M., Hanawa, H., Hu, Y., Hoffer, F.A., Nikanorov, A., Slaughter, C., Ng, C.Y., Zhou, J., Lozier, J.N., Mandrell, T.D., Vanin, E.F., Nienhuis, A.W. (2002). Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. Blood, 100, 1662–9.
   PubMed Web of Science ®Google Scholar
• Pack, D.W., Hoffman, A.S., Pun, S., Stayton, P.S. (2005). Design and development of polymers for gene delivery. Nat Rev Drug Discov, 4, 581–93.
   PubMed Web of Science ®Google Scholar
• Qian, Z.M., Li, H., Sun, H., Ho, K. (2002). Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev, 54, 561–87.
   PubMed Web of Science ®Google Scholar
• Sapra, P., Allen, T.M. (2003). Ligand-targeted liposomal anticancer drugs. Prog Lipid Res, 42, 439–62.
   PubMed Web of Science ®Google Scholar
• Turunen N, Karihtala P, Mantyniemi A, Sormunen R, Holmgren A, Kinnula VL, Soini Y. (2004). Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma. APMIS, 112, 123–32.
   PubMed Web of Science ®Google Scholar
• Wang, S., Luo, J., Lantrip, D.A., Waters, D.J., Mathias, C.J., Green, M.A., Fuchs, P.L., Low, P.S. 1997. Design and synthesis of [111In] DTPA-folate for use as tumor targeted radiopharmaceutical. Bioconjug Chem, 8, 673–9.
   PubMed Web of Science ®Google Scholar
• Zhong, Z.R., Liu, J., Deng, Y., Zhang, Z.R., Song, Q.G., Wei, Y.X., He, Q. (2007). Preparation and characterization of a novel nonviral gene transfer system: procationic-liposome-protamine-DNA complexes. Drug Deliv, 14, 177–83.
   PubMed Web of Science ®Google Scholar
• Zhou, W., Yuan, X., Wilson, A., Yang, L., Mokotoff, M., Pitt, B., Li, S. (2002). Efficient intracellular delivery of oligonucleotides formulated in folate receptor-targeted lipid vesicles. Bioconjug Chem, 13, 1220–5.
   PubMed Web of Science ®Google Scholar